These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27940172)

  • 1. Biomaterials to suppress cancer stem cells and disrupt their tumoral niche.
    Garcia-Mazas C; Csaba N; Garcia-Fuentes M
    Int J Pharm; 2017 May; 523(2):490-505. PubMed ID: 27940172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells and personalized cancer nanomedicine.
    Gener P; Rafael DF; Fernández Y; Ortega JS; Arango D; Abasolo I; Videira M; Schwartz S
    Nanomedicine (Lond); 2016 Feb; 11(3):307-20. PubMed ID: 26785724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells and angiogenesis.
    Zhao Y; Bao Q; Renner A; Camaj P; Eichhorn M; Ischenko I; Angele M; Kleespies A; Jauch KW; Bruns C
    Int J Dev Biol; 2011; 55(4-5):477-82. PubMed ID: 21732274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine in cancer stem cell therapy: from fringe to forefront.
    Tabassum N; Verma V; Kumar M; Kumar A; Singh B
    Cell Tissue Res; 2018 Dec; 374(3):427-438. PubMed ID: 30302547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular matrix niche microenvironment of neural and cancer stem cells in the brain.
    Reinhard J; Brösicke N; Theocharidis U; Faissner A
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):174-183. PubMed ID: 27157088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering cancer stem cell therapies - a role for nanomedicines?
    Schätzlein AG
    Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
    Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
    World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.
    Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K
    Connect Tissue Res; 2015; 56(5):414-25. PubMed ID: 26291921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment for cancer stem cells.
    Kise K; Kinugasa-Katayama Y; Takakura N
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):197-205. PubMed ID: 26362921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of nanomedicine to alter cancer stem cell dynamics: the impact of extracellular vesicles.
    Gener P; Gonzalez Callejo P; Seras-Franzoso J; Andrade F; Rafael D; Abasolo I; Schwartz S
    Nanomedicine (Lond); 2020 Dec; 15(28):2785-2800. PubMed ID: 33191837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics.
    Sreepadmanabh M; Toley BJ
    Biotechnol Adv; 2018; 36(4):1094-1110. PubMed ID: 29559382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
    Krishnamurthy S; Ke X; Yang YY
    Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell niche: the place to be.
    Borovski T; De Sousa E Melo F; Vermeulen L; Medema JP
    Cancer Res; 2011 Feb; 71(3):634-9. PubMed ID: 21266356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the tissue factor pathway in the biology of tumor initiating cells.
    Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
    Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.